[Biological therapy to Crohn's disease with anti-tumor necrosis factor alpha].
Matsumoto
Takayuki
T
Department of Gastroenterology, Osaka City University Graduate School of Medicine.
Oshitani
Nobuhide
N
Arakawa
Tetsuo
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab